Filter By Category
Archives
Share on -
AMFEPRAMONE
Generic Name: AMFEPRAMONE
ABSTRACT -
Amfepramone, also known as diethylpropion, is a sympathomimetic anorectic medicine used in some jurisdictions as a short-term adjunct to diet and lifestyle measures for obesity. It has stimulant-like noradrenergic effects that reduce appetite. Its legal status and availability vary by country because of cardiovascular, psychiatric, and dependence risks.
This document is for structured API information only. It is not a prescribing guide. Clinical use, if any, must follow the approved local label, trial protocol, and specialist medical supervision.
DOSAGE -
- Dosage should be determined only by a qualified healthcare professional.
- Use only where approved and according to the local product label.
- It is generally intended for short-term adjunctive treatment, not cosmetic weight loss or long-term unsupervised use.
- Avoid late dosing if insomnia occurs and never exceed the prescribed dose.
SIDE EFFECTS–
Possible side effects and safety concerns include:
- Dry mouth, unpleasant taste, nausea, constipation, or diarrhoea
- Insomnia, nervousness, irritability, restlessness, or tremor
- Increased heart rate, palpitations, or raised blood pressure
- Headache or dizziness
- Mood changes, anxiety, or rarely psychotic symptoms
- Dependence, tolerance, or withdrawal symptoms with misuse or prolonged high-dose exposure
ALLRGIC REACTIONS–
Hypersensitivity to Amfepramone or related compounds/products may occur. Symptoms may include:
- Rash
- Urticaria
- Angioedema
- Breathing difficulty
- Anaphylaxis
Important: Patients who develop an allergic reaction to Amfepramone should seek immediate medical attention and inform all future healthcare providers of the allergy.
DRUG INTERACTIONS–
Amfepramone may interact with certain medicines, vaccines, protocols, or clinical conditions. Caution is needed with:
- MAO inhibitors are contraindicated because of hypertensive crisis risk.
- Other stimulants, sympathomimetics, or weight-loss drugs increase cardiovascular risk.
- Antihypertensive therapy may be less effective.
- Alcohol and CNS-active medicines may worsen impairment or psychiatric effects.
Patients should inform healthcare providers about all prescription medicines, over-the-counter medicines, herbal products, vaccines, and supplements they are using.
PREAUTIONS–
- Screen for cardiovascular disease, hypertension, arrhythmia, pulmonary hypertension, psychiatric illness, and substance-use risk.
- Monitor blood pressure, pulse, sleep, mood, and weight response.
- Avoid use in pregnancy unless specifically advised by a clinician.
- Use caution in glaucoma, hyperthyroidism, diabetes, and seizure disorders.
WARNINGS –
- Potential for misuse, dependence, tolerance, and withdrawal.
- Serious cardiovascular effects, including pulmonary hypertension and valvular heart disease, have been associated with anorectic agents.
- Do not use with recent MAOI exposure or other weight-loss stimulants unless explicitly directed.
- Keep securely stored and out of reach of children.
Share on -
. Developed by